The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection

Conditions: COVID-19; Vaccine-Preventable Diseases; SARS CoV 2 Infection; Upper Respiratory Tract Infection; Upper Respiratory Disease Interventions: Biological: Novavax COVID-19 vaccine (2023-2024 formula XBB containing); Biological: Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing) Sponsors: Sarang K. Yoon, DO, MOH; Westat; Novavax Not yet recruiting

https://clinicaltrials.gov/study/NCT06065176

Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials